From our Industry Experts

TMCNet:  Research and Markets: China Pharmaceutical Guide 2014 - 9th Edition Out Now

[August 12, 2014]

Research and Markets: China Pharmaceutical Guide 2014 - 9th Edition Out Now

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "China Pharmaceutical Guide 2014 (9th Edition)" report to their offering.

Written by veteran pharma industry executives to help guide international players navigate through the complex and turbulent Chinese healthcare business environment, it is the most authoritative reference on China's pharmaceutical and healthcare business. Extensive coverage on China's pharma industry and healthcare sector, structure and market environment, regulatory framework, healthcare provision and financing, disease & drug consumption patterns, pharma sales, marketing & distribution, trends and opportunities, market entry strategies, case studies of successes and failures in six key areas of the Chinese pharma business, and profiles of leading MNC pharma players in China.

The 2014 edition has been thoroughly updated with sinificantly expanded coverage in recent editions on more sub-sectors, outsourcing, clinical practices, regulatory updates on healthcare reform and drug policies, additional case studies, and latest market / health data updated through mid-2014.

Key Topics Covered:

Part I Overview Of The Chinese Economy And Business

Part II The Chinese Pharmaceutical Industry And Market

Part III Pharmaceutical Regulatory Framework

Part IV Healthcare Provision And Financing

Part V Disease And Drug Consumption Patterns

Part VI Pharmaceutical Sales, Marketing And Distribution In China

Part VII Contemporary Trends, Opportunities And Strategic Considerations

Part VIII Market Entry Strategies And Execution

Part IX Mini Case Studies

Part X Company Profiles: Multinational Pharma Companies In China

Companies Mentioned

  • Abbvie China (Abbott)
  • Astellas China
  • AstraZeneca China
  • Baxter Healthcare China
  • Bayer Healthcare China
  • Beaufour Ipsen China
  • Boehringer Ingelheim China
  • Bristol-Myers Squibb China
  • DSM (News - Alert) China
  • Daiichi Sankyo China
  • Dainippon Sumitomo Pharma China
  • Eisai China
  • Eli Lilly China
  • Fresenius Kabi China
  • GE Healthcare China
  • GlaxoSmithKline China
  • Johnson & Johnson China
  • Kyowa Hakko Kirin China
  • Merck KGAA/Merck Serono China
  • Merck Sharp (News - Alert) & Dhome China
  • Mitsubishi Tanabe Pharma China
  • Novartis China
  • Novo Nordisk China
  • Otsuka China
  • Pfizer China
  • Roche China
  • Sanofi China
  • Stada China
  • TEVA China
  • Takeda China

For more information visit

[ Back To Real Time Communications's Homepage ]


  Subscribe here for RTCW eNews   Upcoming Webinars

Featured Videos

Kandy Wrapper: Visual Attendant
Kandy Visual Attendant is ready for resale. The turnkey solution can be custom branded ...

NFV Made Easy
Moving to an NFV gives you An agile and lower cost network. With GENBAND's NFV Solutions ...
Kandy Bus 2016 Connected Experience
Kandy presents A Connected Experience, a three-part fire-starter where we build entire Kandy-enabled ...

View All